Companion Animal Pharmaceutical Market - Global Outlook and Forecast 2023-2028

Report ID: 1378034 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story

Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
This report contains market size and forecasts of Companion Animal Pharmaceutical in Global, including the following market information:
Global Companion Animal Pharmaceutical Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Companion Animal Pharmaceutical market was valued at 13300 million in 2021 and is projected to reach US$ 20490 million by 2028, at a CAGR of 6.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Infectious Diseases Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Companion Animal Pharmaceutical include Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Virbac, Dechra Veterinary Products, Ceva and Vetoquinol, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Animal Pharmaceutical companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Animal Pharmaceutical Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Companion Animal Pharmaceutical Market Segment Percentages, by Type, 2021 (%)
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other Indications
Global Companion Animal Pharmaceutical Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Companion Animal Pharmaceutical Market Segment Percentages, by Application, 2021 (%)
Dogs
Cats
Other
Global Companion Animal Pharmaceutical Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Companion Animal Pharmaceutical Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Animal Pharmaceutical revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Companion Animal Pharmaceutical revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell

Frequently Asked Questions
Companion Animal Pharmaceutical Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Companion Animal Pharmaceutical Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Companion Animal Pharmaceutical Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports